Caseware UK (AP4) 2023.0.135 2023.0.135 2023-10-302023-10-30false2022-10-31falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 07587357 2022-10-31 2023-10-30 07587357 2021-10-31 2022-10-30 07587357 2023-10-30 07587357 2022-10-30 07587357 2021-10-31 07587357 c:Director1 2022-10-31 2023-10-30 07587357 d:Buildings d:LongLeaseholdAssets 2022-10-31 2023-10-30 07587357 d:Buildings d:LongLeaseholdAssets 2023-10-30 07587357 d:Buildings d:LongLeaseholdAssets 2022-10-30 07587357 d:PlantMachinery 2022-10-31 2023-10-30 07587357 d:PlantMachinery 2023-10-30 07587357 d:PlantMachinery 2022-10-30 07587357 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-10-31 2023-10-30 07587357 d:OfficeEquipment 2022-10-31 2023-10-30 07587357 d:OfficeEquipment 2023-10-30 07587357 d:OfficeEquipment 2022-10-30 07587357 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-10-31 2023-10-30 07587357 d:OtherPropertyPlantEquipment 2022-10-31 2023-10-30 07587357 d:OtherPropertyPlantEquipment 2023-10-30 07587357 d:OtherPropertyPlantEquipment 2022-10-30 07587357 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2022-10-31 2023-10-30 07587357 d:OwnedOrFreeholdAssets 2022-10-31 2023-10-30 07587357 d:Goodwill 2023-10-30 07587357 d:Goodwill 2022-10-30 07587357 d:CurrentFinancialInstruments 2023-10-30 07587357 d:CurrentFinancialInstruments 2022-10-30 07587357 d:Non-currentFinancialInstruments 2023-10-30 07587357 d:Non-currentFinancialInstruments 2022-10-30 07587357 d:CurrentFinancialInstruments d:WithinOneYear 2023-10-30 07587357 d:CurrentFinancialInstruments d:WithinOneYear 2022-10-30 07587357 d:ShareCapital 2023-10-30 07587357 d:ShareCapital 2022-10-30 07587357 d:SharePremium 2023-10-30 07587357 d:SharePremium 2022-10-30 07587357 d:RetainedEarningsAccumulatedLosses 2023-10-30 07587357 d:RetainedEarningsAccumulatedLosses 2022-10-30 07587357 c:OrdinaryShareClass1 2022-10-31 2023-10-30 07587357 c:OrdinaryShareClass1 2023-10-30 07587357 c:OrdinaryShareClass1 2022-10-30 07587357 c:OrdinaryShareClass2 2022-10-31 2023-10-30 07587357 c:OrdinaryShareClass2 2023-10-30 07587357 c:OrdinaryShareClass2 2022-10-30 07587357 c:OrdinaryShareClass3 2022-10-31 2023-10-30 07587357 c:OrdinaryShareClass3 2023-10-30 07587357 c:OrdinaryShareClass3 2022-10-30 07587357 c:OrdinaryShareClass4 2022-10-31 2023-10-30 07587357 c:OrdinaryShareClass4 2023-10-30 07587357 c:OrdinaryShareClass4 2022-10-30 07587357 c:OrdinaryShareClass5 2022-10-31 2023-10-30 07587357 c:OrdinaryShareClass5 2023-10-30 07587357 c:OrdinaryShareClass5 2022-10-30 07587357 c:FRS102 2022-10-31 2023-10-30 07587357 c:AuditExempt-NoAccountantsReport 2022-10-31 2023-10-30 07587357 c:FullAccounts 2022-10-31 2023-10-30 07587357 c:PrivateLimitedCompanyLtd 2022-10-31 2023-10-30 07587357 2 2022-10-31 2023-10-30 07587357 d:AcceleratedTaxDepreciationDeferredTax 2023-10-30 07587357 d:AcceleratedTaxDepreciationDeferredTax 2022-10-30 07587357 e:PoundSterling 2022-10-31 2023-10-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 07587357










WILLIAM HARVEY MEDICAL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 OCTOBER 2023



 
WILLIAM HARVEY MEDICAL LIMITED
REGISTERED NUMBER: 07587357

BALANCE SHEET
AS AT 30 OCTOBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 5 
19,128
28,374

  
19,128
28,374

Current assets
  

Debtors: amounts falling due after more than one year
 6 
445,000
470,000

Debtors: amounts falling due within one year
 6 
168,118
55,500

Cash at bank and in hand
 7 
42,882
197,764

  
656,000
723,264

Creditors: amounts falling due within one year
 8 
(12,664)
(41,966)

Net current assets
  
 
 
643,336
 
 
681,298

Total assets less current liabilities
  
662,464
709,672

Provisions for liabilities
  

Deferred tax
 9 
(942)
(963)

  
 
 
(942)
 
 
(963)

Net assets
  
661,522
708,709


Capital and reserves
  

Called up share capital 
 10 
100
100

Share premium account
  
249,900
249,900

Profit and loss account
  
411,522
458,709

  
661,522
708,709


Page 1

 
WILLIAM HARVEY MEDICAL LIMITED
REGISTERED NUMBER: 07587357

BALANCE SHEET (CONTINUED)
AS AT 30 OCTOBER 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
R MacLaren
Director

Date: 30 July 2024

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023

1.


General information

William Harvey Medical Limited is a private company, limited by share capital and incorporated in England and Wales.
The Company's registered office is The Barn, New Barn Farm, Northampton Road, Weston on the Green, Bicester, Oxfordshire, OX25 3TL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023

2.Accounting policies (continued)


2.7
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on the following basis.

Depreciation is provided on the following basis:

Leasehold Property
-
3 -7 years straight line
Plant & machinery
-
10 years straight line
Office equipment
-
25% reducing balance
Farm equipment
-
25% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

Page 5

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023

2.Accounting policies (continued)

 
2.12

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).

Page 6

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023

4.


Intangible assets




Goodwill

£



Cost


At 31 October 2022
250,000



At 30 October 2023

250,000



Amortisation


At 31 October 2022
250,000



At 30 October 2023

250,000



Net book value



At 30 October 2023
-



At 30 October 2022
-




5.


Tangible fixed assets





Leasehold Property
Plant & machinery
Office equipment
Farm equipment
Total

£
£
£
£
£



Cost or valuation


At 31 October 2022
73,059
10,000
2,424
15,480
100,963



At 30 October 2023

73,059
10,000
2,424
15,480
100,963



Depreciation


At 31 October 2022
59,204
750
2,081
10,554
72,589


Charge for the year on owned assets
6,928
1,000
86
1,232
9,246



At 30 October 2023

66,132
1,750
2,167
11,786
81,835



Net book value



At 30 October 2023
6,927
8,250
257
3,694
19,128



At 30 October 2022
13,855
9,250
343
4,926
28,374

Page 7

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023

6.


Debtors

2023
2022
£
£

Due after more than one year

Other debtors
445,000
470,000


2023
2022
£
£

Due within one year

Other debtors
168,118
55,500

168,118
55,500



7.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
42,882
197,764



8.


Creditors: amounts falling due within one year

2023
2022
£
£

Corporation tax
2,332
34,252

Other creditors
-
4,434

Accruals and deferred income
10,332
3,280

12,664
41,966



9.


Deferred taxation




2023
2022


£

£






At beginning of year
(963)
(701)


Charged to the profit or loss
21
(262)



At end of year
(942)
(963)

Page 8

 
WILLIAM HARVEY MEDICAL LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 OCTOBER 2023
 
9.Deferred taxation (continued)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(942)
(963)

(942)
(963)


10.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



20 (2022 - 20) Ordinary A shares of £1.00 each
20
20
20 (2022 - 20) Ordinary B shares of £1.00 each
20
20
20 (2022 - 20) Ordinary C shares of £1.00 each
20
20
20 (2021 - Nil20) Ordinary D shares of £1.00 each
20
20
20 (2021 - Nil20) Ordinary E shares of £1.00 each
20
20

100

100



11.


Pension commitments

Pension contributions of £67,000 (2022: £36,000) have been recognised in the profit and loss. 


12.


Related party transactions

During the year, the director took a loan of £150,000 of which £35,000 was repaid during the year. At the year end, the director owed the Company £112,617. For the 2022 year end, the Company owed £4,434 to the director. Interest is chargeable at 2% and 2.5% and repayable on demand.


13.


Controlling party

Within other debtors a loan of £500,000 (2022: £525,000) was made to Darwinian Ltd, a company controlled by a common director. The loan is unsecured and repayable over 10 years. Interest has not been applied on the loan. 


Page 9